Skip to main content
Clinical Trials/NL-OMON39868
NL-OMON39868CompletedPhase 3

ROX CONTROL HTN Study: A Prospective, Randomized, Open-Label, Multicenter Study to Evaluate the ROX Coupler in Patients with Resistant Hypertension - ROX CONTROL HT

Clinical Department0 sites15 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
15

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • •1. Office Systolic blood pressure >= 140 mmHg based on an average of 3 blood pressure readings;2. Ambulatory Blood Pressure Monitoring (ABPM) daytime average:
  • •Systolic blood pressure (SBP) >= 135 mmHg;
  • •Diastolic blood pressure (DBP) >= 85 mmHg ;See Protocol Section 4.4.1 for complete Inclusion Criteria

Exclusion Criteria

  • •1. Secondary hypertension attributable to a cause other than sleep apnea
  • •2. Type I diabetes
  • •See Protocol Section 4.4.2 for complete Exclusion Criteria

Investigators

Sponsor
Clinical Department

Similar Trials